Cargando…
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study
The momentum of gene therapy in Huntington's disease (HD) deserves biomarkers from easily accessible fluid. We planned a study to verify whether plasma miRNome may provide useful peripheral “reporter(s)” for the management of HD patients. We performed an exploratory microarray study of whole no...
Autores principales: | Ferraldeschi, Michela, Romano, Silvia, Giglio, Simona, Romano, Carmela, Morena, Emanuele, Mechelli, Rosella, Annibali, Viviana, Ubaldi, Martina, Buscarinu, Maria Chiara, Umeton, Renato, Sani, Gabriele, Vecchione, Andrea, Salvetti, Marco, Ristori, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131841/ https://www.ncbi.nlm.nih.gov/pubmed/34025560 http://dx.doi.org/10.3389/fneur.2021.657973 |
Ejemplares similares
-
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study
por: Romano, Silvia, et al.
Publicado: (2022) -
Genome-Wide Multiple Sclerosis Association Data and Coagulation
por: La Starza, Sara, et al.
Publicado: (2019) -
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
por: Mechelli, Rosella, et al.
Publicado: (2020) -
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022) -
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)